Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation

Platelets

Volumn 18, Issue 5, 2007, Pages 357-364

  Pavanetto, Martina ^a   Zarpellon, Alessandro ^a   Giacomini, Daria ^b   Galletti, Paola ^b   Quintavalla, Arianna ^b   Cainelli, Gianfranco ^b   Folda, Alessandra ^a   Scutari, Guido ^a   Deana, Renzo ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Deparment of Biochemistry   (Italy)

Author keywords

Beta lactam compounds; Cytosolic Ca2+ concentration; Platelet aggregation; Protein kinase C

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE INHIBITOR; AZETIDINONE DERIVATIVE; BETA LACTAM DERIVATIVE; CALCIUM ION; CALCIUM IONOPHORE; COLLAGEN; NITROGEN; PHORBOL ESTER; PLECKSTRIN; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; THAPSIGARGIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; CALCIUM TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

BETA-LACTAMS; BLOOD PLATELETS; BLOOD PROTEINS; CALCIUM; CARCINOGENS; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; HUMANS; MONOBACTAMS; PHORBOL ESTERS; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; THAPSIGARGIN; THROMBIN;

EID: 34547235253     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100601100796     Document Type: Article

References (38)

1. Donowitz GR, Mandell GL. Drug therapy. Beta-lactam antibiotics. N Engl J Med 1988;318:490-500.
2. Turck M. Clinical applications of the newer beta-lactam antibiotics. J Antimicrob Chemother 1988;22(SV):45-62.
3. Holbrook KA, Lowy FD. Beta-lactam antibiotics. Cancer Invest 1998;16:405-412.
4. Kidwai M, Sapra P, Bhushan KR. Synthetic strategies and medicinal properties of beta-lactams. Curr Med Chem 1999;6:195-215.
5. Poole K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci 2004;61:2200-2223.
6. Micetich RG, Salama SM, Maiti SN, Reddy AVN, Singh R. Lactamases and their inhibitors: An update. Curr Med Chem Anti-Infective Agents 2002;1:193-213.
7. Konaklieva MI. β-Lactams as inhibitors of serine enzymes. Curr Med Chem Anti-Infective Agents 2002;1:215-238.
8. Cainelli G, Galletti P, Garbisa S, Giacomini D, Sartor L, Quintavalla A. 4-Alkylidene-azetidin-2-ones: Novel inhibitors of leukocyte elastase and gelatinase. Bioorgan Med Chem 2003;11:5391-5399.
9. Cainelli G, Galletti P, Garbisa S, Giacomini D, Sartor L, Quintavalla A. 4-Alkyliden-beta-lactams conjugated to polyphenols: Synthesis and inhibitory activity. Bioorgan Med Chem 2005;13:6120-6132.
10. Dell'Aica I, Sartor L, Galletti P, Giacomini D, Quintavalla A, Calabrese F, Brunetta E, Piazza F, Agostini C, Garbisa S. Inhibition of leukocyte elastase, PMN chemoinvasion, and inflammation-triggered pulmonary fibrosis by a 4-alkyliden-betalactam with a galloyl moiety. J Pharmacol Exp Ther 2006;316:539-546.
11. Cazenave JP, Guccione MA, Packham MA, Mustard JF. Effects of cephalothin and penicillin G on platelet function in vitro. Br J Hematol 1977;35:135-152.
12. 2 generation and arachidonic acid release in rabbit platelets in vitro. Thromb Res 1986;44:265-275.
13. Shattil SJ, Bennett JS, McDonough M, Turnbull J. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with platelet surface. J Clin Invest 1980;65:329-337.
14. Burroughs SF, Johnson GJ. β-lactam antibiotic-induced platelet dysfunction: Evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin. Blood 1990;75:1473-1480.
15. Pastakia K, Terle D, Prodouz KN. Penicillin-induced dysfunction of platelet membrane glycoproteins. J Lab Clin Med 1993;121:546-554.
16. Leblond L, Grouix B, Boudreau C, Yang Q, Siddiqui MA, Winocour PD. In vitro and in vivo properties of bicyclic lactam inhibitors: A novel class of low molecular weight peptidomimetic thrombin inhibitors. Thromb Res 2000;100:195-209.
17. Brown CH, Natelson EA, Bradshaw W, Williams TW Jr, Alfrey CP Jr. The hemostatic defect produced by carbenicillin. N Engl J Med 1974;291:265-270.
18. Togna GI, Togna AR, Caprino L. β-lactam antibiotic-mediated changes in platelet reactivity and vascular endothelial functions. Pharmacol Toxicol 2000;88:277-281.
19. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: To the integrins and beyond. Thromb Haemost 1997;78:581-589.
20. Brass LF. Thrombin and platelet activation. Chest 2003;124:18S-25S.
21. Cainelli G, Galletti P, Gazzano M, Giacomini D, Quintavalla A. Synthesis of novel 4-(1-ethoxycarbonylmethylidene)-azetidin-2-ones via a Lewis acid-catalyzed reaction of ethyl diazoacetate. Tetrahedron Lett 2002;43:233-235.
22. Cainelli G, Giacomini D, Gazzano M, Galletti P, Quintavalla A. N-Acylation of 4-alkylidene-β-lactams: Unexpected results. Tetrahedron Lett 2003;44:6269-6272.
23. Francesconi MA, Scapin M, Casonato A, Girolami A, Deana R. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes. Tromb Res 2000;100:293-303.
24. 2+ concentration, protein phosphorylation and platelet secretion. Cell Calcium 1996;20:431-440.
25. Jin Y-R, Ryu C-K, Moon C-K, Cho M-R, Yun Y-P. Inhibitory effects of J78, a newly synthesized 1,4-naphtoquinone derivative, on experimental thrombosis and platelet aggregation. Pharmacology 2004;70:195-200.
26. Back SA, Khan R, Gan X, Rosenberg PA, Volpe JJ. A new Alamar blue viability assay to rapidly quantify oligodendrocyte death. J Neurosci Meth 1999;91:47-54.
27. 2 formation. J Biol Chem 1991;266:19232-19237.
28. 2+ influx. Nature 1993;364:809-814.
29. Vassallo RR Jr, Kieber-Emmons T, Cichowski K, Brass L. Structure-function relationship in the activation of platelet thrombin receptor by receptor-derived peptides. J Biol Chem 1992;267:6081-6085.
30. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989;69:58-178.
31. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661-665.
32. De Chaffoy de Courcelles D. The role of protein kinase C in the human platelet. Blood Coagul Fibrinolysis 1990;1:401-413.
33. Needleman P, Turk J, Jackshik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 1986;55:69-102.
34. McDonald H. Overview of hemostasis and thrombosis; current status of antithrombotic therapies. Thromb Res 2005;117:15-17.
35. Nutescu EA, Shapiro NL, Chevalier A, Amin AN. A pharmacologic overview of current and emerging anticoagulants. Cleve Clin J Med 2005;72(1):S2-S6.
36. Meyer BJ. Antithrombotic drugs: Insights from cardiology. Cerebrovasc Dis 1998;8:19-27.
37. Burroughs SF, Johnson GJ. Beta-lactam antibiotics inhibit agonist-stimulated platelet calcium influx. Thromb Haemost 1993;69:503-508.
38. 2+ stores. Biochem J 1990;265:675-680.